For cancer patients, clinical trials mean hope. Hope for a cancer-free world and for better, more targeted ways to prevent, detect, treat and cure individual cancers.

Patients can enter clinical trials before, during or after starting their cancer treatment.

The internationally recognized experts at the OSUCCC – James believe the best way to treat patients and manage their disease successfully is to be at the forefront of delivering the latest, most effective treatments available and by working with nationally and internationally renowned experts to develop the newest and best individualized cancer treatments and programs.

The OSUCCC – James has more than 500 open clinical trials at any given time, with some of the world’s latest discoveries available to clinical trial patients right here in Columbus, Ohio, USA. In fact, patients have access to more of this nation’s leading-edge, targeted treatments and cancer clinical trials here than at nearly any other hospital in the region, as well as access to some of the most advanced, targeted treatments and drugs.

Additionally, the OSUCCC – James is one of only four U.S. cancer centers funded by the National Cancer Institute (NCI) to conduct phase I and phase II clinical trials. These trials go only to centers that demonstrate an exemplary capacity for research and clinical care, the expertise to deliver the latest in treatments and the infrastructure to interpret and track treatment results.

The OSUCCC – James and Ohio State have nearly 300 cancer researcher scientists dedicated to understanding what makes each patient’s cancer grow, spread or reoccur. And because of the OSUCCC – James’ NCI phase I and phase II approvals, these experts can move research discoveries into clinical trials and get them to patients sooner, which can mean improved outcomes, faster responses and fewer side effects.

The OSUCCC – James Destination Medicine Global Health Care team is available 24 hours a day, seven days a week. Please feel free to contact our office at 614-685-5422 (domestic calls) or 001-614-685-5422 (international calls), or email us at destinationmedicine@osumc.edu.

Who Should Participate in a Clinical Trial

For some patients, taking part in a clinical trial may be the best treatment choice. Patients can enter clinical trials before, during or after starting their cancer treatment.

The OSUCCC – James is one of only four institutions funded by the National Cancer Institute (NCI) to conduct phase I and II clinical trials on NCI–sponsored anticancer drugs.

If you’ve been diagnosed with cancer, would like a remote consultation or would like to speak with a Destination Medicine Global Health Care team member to coordinate care at the OSUCCC – James, please contact our office at 614-685-5422 (domestic calls) or 001-614-685-5422 (international calls), or email us at destinationmedicine@osumc.edu.

Contact
Destination Medicine

Phone: 001-614-685-5422


Fax: 001-614-366-5297


DestinationMedicine@osumc.edu